Journal of Preventive Cardiology
spacer
Current Issue

Review Article

Year: 2016 I  Volume: 6I  Issue: 1I  Pages:965–972
 
Looking beyond LDL-Cholesterol level at LDL particle number
Soumitra Kumar*, Chanchal Samanta†, Soutrik Kumar‡
*Professor and Head of the Department (Cardiology), Vivekananda Institute of Medical Sciences, Kolkata.
†Post-graduate trainee (MD-Medicine), Vivekananda Institute of Medical Sciences, Kolkata.
‡Junior Resident, Department of Medicine, KPC Medical College, Kolkata.

 

Abstract

Low-density lipoprotein cholesterol (LDL-C) level is an established cardiovascular disease (CVD) risk marker based on the results of various clinical trials. Most lipid lowering strategies are focused on reducing LDL-C to reduce cardiovascular risk. However, ample evidences show that LDL-C measurement and treatment alone is not the optimal strategy for reducing CVD risk.

Controversy remains whether we are using the best measure(s) of LDL-C characteristics to identify all individuals who are at CVD risk or if they would gain from specific therapies. Despite successful LDL-C reduction trials, considerable numbers of patients suffer from cardiovascular events in the treatment groups.

LDL-C measurement may not reflect a patient's true LDL-related risk due to the variable cholesterol content of LDL particles. Mismatch increases to one in two in the presence of diabetes mellitus, hypertriglyceridemia, low high-density lipoprotein cholesterol (HDL-C), or low LDL-C level. Various limitations make LDL-C a less accurate marker of CVD risk than non-HDL-C, LDL particle number (LDL-P), or apolipoprotein B (apoB).

Other triglyceride-rich lipoproteins including very-low-density lipoprotein (VLDL) remnants and intermediate-density lipoproteins (IDL) are also atherogenic.

The size of LDL particles and assessment of LDL-P by nuclear magnetic resonance spectroscopy have been suggested as a more reliable cardiovascular risk marker. Because the cholesterol content per LDL particle exhibits large inter-individual variation, the information provided by LDL-C and LDL-P is not equivalent.1-7 Individuals with the same level of LDL-C may have higher or lower LDL-P, and therefore, may differ in terms of absolute CVD risk.1-7 Higher LDL-P indicates higher risk and an opportunity for further LDL management.1-7

Recent studies investigated the importance of LDL-particle size. People with predominantly small and dense LDL particles have a threefold greater risk of coronary heart disease. The large and fluffy type of LDL may also be protective.

LDL particle number and size may be used more often in the future to assess cardiovascular risk. Here, we discuss the role of LDL-P as a more appropriate cardiovascular risk marker beyond LDL-C.

 
Keywords
Cardiovascular disease
Low-density lipoprotein cholesterol
Low-density lipoprotein particle number
Non-high-density lipoprotein cholesterol
Nuclear magnetic resonance
 
[Full Text]
Print this Article
Back to main page
Slideshow
  • State-of-the-Art Article
    Mildly Elevated Blood Pressure: What to do?
    -Dr. Arvind K. Pancholia.
    abstract text full text
  • Original Article
    Heart Failure Entities Peculiar to India
    -Dr. T Govindan Unni
    abstract text full text
  • Original Article
    Saturated Fat: Friend or Foe?
    -Dr. T Govindan Unni
    abstract text full text
  • Update on Statins
    abstract text full text
  • Update on Guidelines
    2018 Guideline on the Management of Blood Cholesterol
    full text
  • Updates on Guidelines
    ACC Consensus on New Diabetes Drugs to Reduce CV Outcomes
    full text
  • News and Views
     
    full text
spacer
Slideshow
  • 2nd World Congress on Cardiac Imaging and Clinical Cardiology 2019
    To be held on Feb 22–24, 2019, Mumbai, India
    Read more...
  • INDIA LIVE 2019
    To be held on Feb 28–Mar 3, 2019,Mumbai
    Read more...
  • Saudi Heart Association 30th Annual Meeting 2019 (SHA 2019)
    To be held on Mar 7–9, 2019, Riyadh, Saudi Arabia
    Read more...
  • American College of Cardiology 68th Annual Scientific Session and Expo
    To be held on Mar 16–18, 2019, New Orleans, LA
    Read more...
  • International Symposium on Endovascular Therapeutics - SITEUpdate 2019
    To be held on Mar 27–29, 2019, Barcelona, Spain
    Read more...
Journal of Preventive Cardiology
spacer
 
spacer
Print ISSN: 2249-4308
Online ISSN: 2277-6559
 
Frequency: Quarterly
 
 
Email This
close
 
 
  [ Separate multiple email addresses with commas (Limit is 10). ]